February 13, 2026 · Form 4 insider transaction
Bunnage Mark E. sold 2,283 shares of Vertex Pharmaceuticals Incorporated at $487.76 per share, a transaction worth $1.11M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.